reduced r-chop in favourable-prognosis dlbcl doesn't compromise outlook
Published 5 years ago • 692 plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
1:12
smart stop: moving away from r-chop in dlbcl
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
2:33
tailoring chemotherapy: r-chop dose attenuation in elderly dlbcl
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
1:27
atezolizumab plus r-chop in dlbcl: encouraging results
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
29:38
dlbcl treatment approaches: what you need to know
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
1:23
findings from the ro-chop trial in patients with r/r ptcl
-
1:23
phoenix: ibrutinib in combination with r-chop for dlbcl
-
1:00
phase ib trial of r-chop plus iberdomide or cc-99282 in aggressive b-cell lymphoma
-
2:42
final analysis of the ro-chop trial: romidepsin plus chop vs chop in previously untreated ptcl
-
0:42
targeted therapies for dlbcl treatment
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:56
upcoming trials for dlbcl: r-chop with acalabrutinib and obinutuzumab with checkpoint inhibitor
-
16:10
is frontline r-chop still the standard of care for dlbcl?
-
2:43
first report of phase 3 robust trial: r2-chop for frontline dlbcl
-
1:22
safety and efficacy of cc-99282 in the treatment of r/r nhl
-
5:40
developments in b-cell lymphoma management